Nagi F Idris's scientific contributions

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (3)


Figure 2: Bystander killing effect. 
Figure 3: Prodrug converted in to active drug by enzymes. 
Nanomedicine to Tumor by Enzymosomes
  • Article
  • Full-text available

March 2015

·

296 Reads

·

6 Citations

Yallappamaharaj R Hundekar

·

·

Anas S Mohamied

·

[...]

·

Azam Sharif Md Shafioul

Usually the enzymes have played a role in enhancing prodrug activation for active targeting by an antibody. In routine practice the use of enzymes is a difficult task due to the loss of activity by their degradation, although they do not have a capacity of penetrating into biological membrane, such a task is handled by placing the enzymes in suitable location i.e., encapsulating an enzyme to the surface of the lipid vesicles or surface of liposomes are called enzymosomes, thus the covalent link of enzymes will minimize alterations of the activity of enzymes, enhances half-life and achieved enzyme activity at targeted site such as tumour cell. The review article includes preparation techniques, characterization and stability of liposomal enzymes drug delivery system.

Download
Share

Formulation and Evaluation of Enalapril Maleate Biodegradable Microspheres

September 2014

·

1,778 Reads

·

5 Citations

Journal of Pharmaceutical Sciences and Pharmacology

Enalapril maleate was incorporated into natural biodegradable polymer egg albumin microspheres for controlled release and to investigate the in vitro and in vivo studies in the treatment of hypertension. The microspheres were developed by chemical cross linking technique and glutaraldehyde was used as chemical cross linking agent. The size of formulated microspheres observed in the range of 50 to 60 μm and encapsulation efficiency of Enalapril maleate was up to 89.10%. In vitro studies reported the release of 85.44% Enalapril maleate loaded egg albumin microspheres after 6 hrs. In vivo studies carried out in wistar rats exhibited that, optimized formulation reduces the blood pressure and pharmacokinetic analysis such as C max, TM max and AUC was found to be 12.8 μm/ml, 4 hr and 56.25 g/hr/ml respectively. Elimination constant and t 1/2 of microspheres formulation was observed to be 0.0389 and 17 hrs. Stability studies were carried out at different temperature for 30 days which reported the reduction in drug content at very low amount. From these result, it was concluded that, the formulated egg albumin microspheres of Enalapril maleate is a potential delivery system to reduce the blood pressure. So the controlled release achieved through natural biodegradable polymer egg albumin microspheres.


Figure 2: Hemoglobin encapsulated within liposomes. 
Figure 3: Manufacturing technique of Liposome-Encapsulated Hemoglobin (LEH) preparation. 
Austin Journal of Analytical and Pharmaceutical Chemistry

August 2014

·

193 Reads

Abstract: Haem is found in all living cells as well tissues in the form of proteins suchas cytochromes, hemoglobin’s and peroxides. This is act as catalyst for theformation of oxygen radicals. Encapsulation of haem or hemoglobin with in lipidvesicles or liposome’s is called “Hemosomes” or it is also called Liposomeencapsulatedhemoglobin (LEH). Which are 0.1 to 10 microns in dimension, andit is a technology of preparing artificial red blood substitutes. The synthetic cellsare stable being somewhat smaller and stronger than normal red blood cells andare having same electrophoretic movements. Hemoglobin (Hb) encapsulationwithin a liposome is one of the strategies in the development of artificial oxygen carriers. The review article includes preparation techniques, characterizationand stability of Hemosomal drug delivery system.

Citations (2)


... There are two main approaches to carry out enzyme activated prodrug therapy method; Gene-directed enzyme prodrug therapy (GDEPT) and Antibody directed enzyme prodrug therapy (ADEPT) [15]. Both methods activate inactive prodrug when the prodrug is reached at the cancer area which is more illustrated below (Figure1). ...

Reference:

Future Prospective of Targeted Therapeutic Approaches over Conventional Therapies for Various Cancer Types
Nanomedicine to Tumor by Enzymosomes

... The extent of absorption of enalapril maleate after oral administration is approximately 60% and due to the high hepatic first-pass metabolism of the prodrug (enalapril maleate) to the active form of the drug (enalaprilat) in the gastrointestinal tract before absorption the bioavailability of enalaprilat becomes approximately 40%. 16 The objective of the present study was to overcome the reduction in bioavailability as a result of the lack of absorption. An attempt is needed to provide a control drug delivery system through this newly approved work for enhancing the absorption and bioavailability of enalapril maleate loaded floating microspheres by ionotropic gelation technique using a hydrophilic carrier. ...

Formulation and Evaluation of Enalapril Maleate Biodegradable Microspheres

Journal of Pharmaceutical Sciences and Pharmacology